Cargando…

High expression levels of CLEC4M indicate poor prognosis in patients with hepatocellular carcinoma

The identification of novel and accurate biomarkers is important to improve the prognosis of patients with hepatocellular carcinoma (HCC). C-Type lectin domain family 4 member M (CLEC4M) is involved in the progression of numerous cancer types. However, the clinical significance of CLEC4M in HCC is y...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Liuping, Chen, Lihong, Ke, Kun, Zhao, Bixing, Wang, Lili, Zhang, Cuilin, Wang, Fei, Liao, Naishun, Zheng, Xiaoyuan, Liu, Xiaolong, Wang, Yingchao, Liu, Jingfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038977/ https://www.ncbi.nlm.nih.gov/pubmed/32194663 http://dx.doi.org/10.3892/ol.2020.11294

Ejemplares similares

Evaluation and prediction of hepatocellular carcinoma prognosis based on molecular classification
por: Ke, Kun, et al.
Publicado: (2018)

An Optogenetic Controllable T Cell System for Hepatocellular Carcinoma Immunotherapy
por: Zhao, Bixing, et al.
Publicado: (2019)

FGG promotes migration and invasion in hepatocellular carcinoma cells through activating epithelial to mesenchymal transition
por: Zhang, Xiang, et al.
Publicado: (2019)

MT1G serves as a tumor suppressor in hepatocellular carcinoma by interacting with p53
por: Wang, Yingchao, et al.
Publicado: (2019)

Antioxidants inhibit cell senescence and preserve stemness of adipose tissue-derived stem cells by reducing ROS generation during long-term in vitro expansion
por: Liao, Naishun, et al.
Publicado: (2019)

High expression of B7-H2 or B7-H3 is associated with poor prognosis in hepatocellular carcinoma
por: Zheng, Youshi, et al.
Publicado: (2019)

Antioxidant preconditioning improves therapeutic outcomes of adipose tissue-derived mesenchymal stem cells through enhancing intrahepatic engraftment efficiency in a mouse liver fibrosis model
por: Liao, Naishun, et al.
Publicado: (2020)

Inflammatory Micro-environment Contributes to Stemness Properties and Metastatic Potential of HCC via the NF-κB/miR-497/SALL4 Axis
por: Zhao, Bixing, et al.
Publicado: (2019)

HIF-1α and HDAC1 mediated regulation of FAM99A-miR92a signaling contributes to hypoxia induced HCC metastasis
por: Zhao, Bixing, et al.
Publicado: (2020)

LncRNA TIALD contributes to hepatocellular carcinoma metastasis via inducing AURKA lysosomal degradation
por: Wang, Yingchao, et al.
Publicado: (2023)

Low Expression of CLEC2B Indicates Poor Prognosis in Melanoma
por: Zhang, Yanqiu, et al.
Publicado: (2023)

Magnetically responsive nanoplatform targeting circRNA circ_0058051 inhibits hepatocellular carcinoma progression
por: You, Song, et al.
Publicado: (2022)

Adipose tissue-derived stem cells ameliorate hyperglycemia, insulin resistance and liver fibrosis in the type 2 diabetic rats
por: Liao, Naishun, et al.
Publicado: (2017)

4E-BP1(Thr46) Phosphorylation Association with Poor Prognosis in Quantitative Phosphoproteomics of Portal Vein Tumor Thrombus Revealed that 4E-BP1Thr46 Phosphorylation is Associated with Poor Prognosis in HCC
por: Lin, Xincong, et al.
Publicado: (2020)

The serum proteomics tracking of hepatocellular carcinoma early recurrence following radical resection
por: Liu, Hongzhi, et al.
Publicado: (2019)

Decrease of Fibulin-3 in Hepatocellular Carcinoma Indicates Poor Prognosis
por: Luo, Rongzhen, et al.
Publicado: (2013)

CLEC4M is associated with poor prognosis and promotes cisplatin resistance in NSCLC patients
por: Tan, Li-Ming, et al.
Publicado: (2019)

Lnc-PLA2G4A-4 facilitates the progression of hepatocellular carcinoma by inducing versican expression via sponging miR-23b-3p
por: Xiong, Jiahui, et al.
Publicado: (2023)

CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients
por: Yao, Yang, et al.
Publicado: (2019)

Poly (dopamine) coated superparamagnetic iron oxide nanocluster for noninvasive labeling, tracking, and targeted delivery of adipose tissue-derived stem cells
por: Liao, Naishun, et al.
Publicado: (2016)

3D-cultured adipose tissue-derived stem cells inhibit liver cancer cell migration and invasion through suppressing epithelial-mesenchymal transition
por: Xie, Haihua, et al.
Publicado: (2018)

Development of Prognostic Evaluation Model to Predict the Overall Survival and Early Recurrence of Hepatocellular Carcinoma
por: Zhong, Yue, et al.
Publicado: (2021)

CLEC4M overexpression inhibits progression and is associated with a favorable prognosis in hepatocellular carcinoma
por: Yu, Qianle, et al.
Publicado: (2020)

Quantitative Secretome Analysis Reveals Clinical Values of Carbonic Anhydrase II in Hepatocellular Carcinoma
por: Xing, Xiaohua, et al.
Publicado: (2021)

Overexpression of CLEC3A promotes tumor progression and poor prognosis in breast invasive ductal cancer
por: Ni, Jun, et al.
Publicado: (2018)

LCMT1 indicates poor prognosis and is essential for cell proliferation in hepatocellular carcinoma
por: Zhang, Ning, et al.
Publicado: (2022)

Increased Expression of CAP2 Indicates Poor Prognosis in Hepatocellular Carcinoma()()
por: Fu, Jia, et al.
Publicado: (2015)

Chemotherapeutic Drug Based Metal–Organic Particles for Microvesicle‐Mediated Deep Penetration and Programmable pH/NIR/Hypoxia Activated Cancer Photochemotherapy
por: Zhang, Da, et al.
Publicado: (2018)

MMP16 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma
por: Shen, Zhenghai, et al.
Publicado: (2017)

Overexpression of SCAMP3 is an indicator of poor prognosis in hepatocellular carcinoma
por: Zhang, Xinyuan, et al.
Publicado: (2017)

Smart Cu(II)-aptamer complexes based gold nanoplatform for tumor micro-environment triggered programmable intracellular prodrug release, photodynamic treatment and aggregation induced photothermal therapy of hepatocellular carcinoma
por: Zhang, Da, et al.
Publicado: (2017)

CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment
por: Zhang, Yinjiang, et al.
Publicado: (2021)

Comprehensive analysis identifies CLEC1B as a potential prognostic biomarker in hepatocellular carcinoma
por: Jing, Qiangan, et al.
Publicado: (2023)

Upregulation of liver kinase B1 predicts poor prognosis in hepatocellular carcinoma
por: Tan, Xiaolong, et al.
Publicado: (2018)

RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma
por: Wang, Wei, et al.
Publicado: (2017)

Sperm-Associated Antigen 5 Expression Is Increased in Hepatocellular Carcinoma and Indicates Poor Prognosis
por: Zhou, Hua, et al.
Publicado: (2018)

High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma
por: Wang, Xuequan, et al.
Publicado: (2022)

High USP22 expression indicates poor prognosis in hepatocellular carcinoma
por: Tang, Bo, et al.
Publicado: (2015)

Positive expression of ZNF689 indicates poor prognosis of hepatocellular carcinoma
por: Yi, Peng Sheng, et al.
Publicado: (2018)

Linc00511 Indicates A Poor Prognosis Of Liver Hepatocellular Carcinoma
por: Hu, Pingan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cr844f90ifm02tgnd354ivpabv